GSK:NYSE
GSK plc
46,54 US$
arrow_downward
-1,02%(-0,48) 1D
46,54 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 8 ოქტ, 16:00:02 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GSK...
Open
46,40 US$
High
46,70 US$
Low
45,82 US$
Mkt. cap
94,29 მლრდ.
Avg. vol.
3,51 მლნ.
Volume
7,73 მლნ.
Dividend
3,90%
Quarterly dividend
0,45 US$
Ex-dividend date
13 აგვ. 2026
P/E ratio
14,86
52-wk high
61,70 US$
52-wk low
42,84 US$
EPS
3,13 US$
Beta
0,25
Shares outstanding
2,16 მლრდ.
No. of employees
67 ათ.
Open
46,40 US$
High
46,70 US$
Low
45,82 US$
Mkt. cap
94,29 მლრდ.
Avg. vol.
3,51 მლნ.
Volume
7,73 მლნ.
Dividend
3,90%
Quarterly dividend
0,45 US$
Ex-dividend date
13 აგვ. 2026
P/E ratio
14,86
52-wk high
61,70 US$
52-wk low
42,84 US$
EPS
3,13 US$
Beta
0,25
Shares outstanding
2,16 მლრდ.
No. of employees
67 ათ.
News stories
From web sources and news partners
AD HOC NEWS
·
3 საათის წინ
GSK launches shingles campaign: stock after-hours at EUR 20.55, down 2.10 percent
TipRanks
·
5 საათის წინ
GSK Director Wendy Becker Joins Tesco Board as Non-Executive
Financial-News.co.uk
·
7 საათის წინ
GSK Passive Income Stock Draws ISA Buyers Despite Cost-Savings Push
Stock Titan
·
8 საათის წინ
Viola Davis says shingles pain was 9 out of 10. She couldn't work.
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About GSK plc
CEOემა უოლმსლი | ემა უოლმსლი
Employees66,8 ათ.
Founded27 დეკ. 2000
Headquarters-
SectorPharmaceutical industry
Websitegsk.com